AvCommittee on the Public Health Effectiveness of the FDA 510(k) Clearance Process,Board on Population Health and Public Health Practice
443 kr
Läs direkt i Bokus Reader – eller ladda ned till din enhet (PDF kräver ofta zoom och scroll på små skärmar).
The Food and Drug Administration (FDA) is responsible for assuring that medical devices are safe and effective before they go on the market. As part of its assessment of FDA''s premarket clearance process for medical devices, the IOM held a workshop June 14-15 to discuss how to best balance patient safety and technological innovation. This document summarizes the workshop.
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Theresa Wizemann
Häftad, 2010
702 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine
836 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine
919 kr
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Theresa Wizemann
Häftad, 2011
408 kr
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process
Häftad, 2011
523 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine, Theresa Wizemann
635 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine, Theresa Wizemann
577 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine, Theresa Wizemann
602 kr
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Theresa Wizemann
Häftad, 2011
408 kr
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Theresa Wizemann
Häftad, 2010
702 kr
Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process
Häftad, 2011
523 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine
836 kr
Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine
919 kr
Roundtable on Population Health Improvement, Board on Population Health and Public Health Practice, Institute of Medicine, Theresa Wizemann, Darla Thompson
652 kr
Roundtable on Population Health Improvement, Board on Population Health and Public Health Practice, Health and Medicine Division, and Medicine National Academies of Sciences, Engineering, Theresa Wizemann
552 kr
